Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.
- 6 February 1996
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 93 (3), 1093-1096
- https://doi.org/10.1073/pnas.93.3.1093
Abstract
Human cancer cells with a mutated p53 tumor-suppressor gene have a selective growth advantage and may exhibit resistance to ionizing radiation and certain chemotherapeutic agents. To examine the prognostic value of mutations in the p53 gene, a cohort of 90 Midwestern Caucasian breast cancer patients were analyzed with methodology that detects virtually 100% of all mutations. The presence of a p53 gene mutation was by far the single most predictive indicator for recurrence and death (relative risks of 4.7 and 23.2, respectively). Direct detection of p53 mutations had substantially greater prognostic value than immunohistochemical detection of p53 overexpression. Analysis of p53 gene mutations may permit identification of a subset of breast cancer patients who, despite lack of conventional indicators of poor prognosis, are at high risk of early recurrence and death.Keywords
This publication has 25 references indexed in Scilit:
- Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting.1995
- Parameters affecting the sensitivities of dideoxy fingerprinting and SSCP.Genome Research, 1994
- A comparison of the biological activities of wild‐type and mutant p53The FASEB Journal, 1993
- Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.1993
- p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic GradeJapanese Journal of Cancer Research, 1993
- Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers.1993
- p53 mutations occur in aggressive breast cancer.1992
- p53, guardian of the genomeNature, 1992
- Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutationsGenomics, 1992